CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objecti ...
Phase 3
Indianapolis, Indiana, United States and 23 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Indianapolis, Indiana, United States and 213 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Indianapolis, Indiana, United States and 176 other locations
in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian...
Phase 3
Indianapolis, Indiana, United States and 117 other locations
Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)....
Phase 1, Phase 2
Indianapolis, Indiana, United States and 24 other locations
in participants with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer...
Phase 3
Indianapolis, Indiana, United States and 213 other locations
This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer...
Phase 3
Indianapolis, Indiana, United States and 196 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Indianapolis, Indiana, United States and 237 other locations
survival (PFS) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as assessed by the investigator. The hypotheses are that pembro...
Phase 3
Indianapolis, Indiana, United States and 186 other locations
The primary objective of this study is to evaluate progression-free survival (PFS) by blinded independent central review (BICR) in patients treated w...
Phase 3
Indianapolis, Indiana, United States and 116 other locations
Clinical trials
Research sites
Resources
Legal